Pharmaceuticals, Biotechnology and Life Sciences
Novel treatment for PSVT developed with Milestone Pharmaceuticals CRYSTAL LAKE, Ill.–(BUSINESS WIRE)–Aptar Group, Inc. (NYSE: ATR), a global leader in…
DUBLIN–(BUSINESS WIRE)–The “Malabsorption Syndrome Market – Global Strategic Business Report” has been added to ResearchAndMarkets.com’s offering. The global market for…
DUBLIN–(BUSINESS WIRE)–The “Constipation Treatment – Global Strategic Business Report” has been added to ResearchAndMarkets.com’s offering. The global market for Constipation…
Minjuvi® (tafasitamab) in combination with lenalidomide and rituximab is the first CD19- and CD20-dual-targeted immunotherapy combination regimen approved for eligible…
SEATTLE & TOKYO–(BUSINESS WIRE)–Talus Bioscience, Inc. (“Talus Bio”), an AI-enabled regulome therapeutics company, today announced a strategic collaboration with PRISM…
DUBLIN–(BUSINESS WIRE)–The “Short Bowel Syndrome (SBS) – Global Strategic Business Report” has been added to ResearchAndMarkets.com’s offering. The global market…
DUBLIN–(BUSINESS WIRE)–The “Drug Discount Cards Market – Global Strategic Business Report” has been added to ResearchAndMarkets.com’s offering. The global market…
IRVINE, Calif.–(BUSINESS WIRE)–RIS Rx, a healthcare technology company offering gross-to-net (GTN) revenue protection and saving more than $1 billion for…
COLUMBUS, Ohio–(BUSINESS WIRE)–DNA Nanobots, a pioneer in self-assembling nanoscale therapeutics, today announced it has secured $3.5 million in funding from…
First-of-its-kind hospitality partnership brings biotech-backed ‘social wellness’ to one of the world’s premier après destination resorts SAN FRANCISCO–(BUSINESS WIRE)–ZBiotics®, the…